innovative pharmaceuticals

AI and robots are still in the “hype expectation” phase of strategic investment, with a chaotic commercialization path and application scenarios lagging behind technological hype. The demand for shovels (AI computing power and chips) has surged, but AI companies and humanoid robots have yet to see signs of profitability. There are breakthroughs in the B2B … Read more